Luspatercept: a candidate to dethrone erythropoietin in first line in low-risk myelodysplastic syndromes?

被引:0
作者
Robert-Van Houtteghem, Tristan
机构
来源
HEMATOLOGIE | 2023年 / 29卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:269 / 271
页数:3
相关论文
共 5 条
[1]  
Bernard E, 2022, NEJM EVID, V1, DOI [10.1056/evidoa2200008, 10.1056/EVIDoa2200008]
[2]   Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes [J].
Fenaux, Pierre ;
Platzbecker, Uwe ;
Mufti, Ghulam J. ;
Garcia-Manero, Guillermo ;
Buckstein, Rena ;
Santini, Valeria ;
Diez-Campelo, Maria ;
Finelli, Carlo ;
Cazzola, Mario ;
Ilhan, Osman ;
Sekeres, Mikkael A. ;
Falantes, Jose F. ;
Arrizabalaga, Beatriz ;
Salvi, Flavia ;
Giai, Valentina ;
Vyas, Paresh ;
Bowen, David ;
Selleslag, Dominik ;
DeZern, Amy E. ;
Jurcic, Joseph G. ;
Germing, Ulrich ;
Goetze, Katharina S. ;
Quesnel, Bruno ;
Beyne-Rauzy, Odile ;
Cluzeau, Thomas ;
Voso, Maria-Teresa ;
Mazure, Dominiek ;
Vellenga, Edo ;
Greenberg, Peter L. ;
Hellstrom-Lindberg, Eva ;
Zeidan, Amer M. ;
Ades, Lionel ;
Verma, Amit ;
Savona, Michael R. ;
Laadem, Abderrahmane ;
Benzohra, Aziz ;
Zhang, Jennie ;
Rampersad, Anita ;
Dunshee, Diana R. ;
Linde, Peter G. ;
Sherman, Matthew L. ;
Komrokji, Rami S. ;
List, Alan F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02) :140-151
[3]   Revised International Prognostic Scoring System for Myelodysplastic Syndromes [J].
Greenberg, Peter L. ;
Tuechler, Heinz ;
Schanz, Julie ;
Sanz, Guillermo ;
Garcia-Manero, Guillermo ;
Sole, Francesc ;
Bennett, John M. ;
Bowen, David ;
Fenaux, Pierre ;
Dreyfus, Francois ;
Kantarjian, Hagop ;
Kuendgen, Andrea ;
Levis, Alessandro ;
Malcovati, Luca ;
Cazzola, Mario ;
Cermak, Jaroslav ;
Fonatsch, Christa ;
Le Beau, Michelle M. ;
Slovak, Marilyn L. ;
Krieger, Otto ;
Luebbert, Michael ;
Maciejewski, Jaroslaw ;
Magalhaes, Silvia M. M. ;
Miyazaki, Yasushi ;
Pfeilstoecker, Michael ;
Sekeres, Mikkael ;
Sperr, Wolfgang R. ;
Stauder, Reinhard ;
Tauro, Sudhir ;
Valent, Peter ;
Vallespi, Teresa ;
van de Loosdrecht, Arjan A. ;
Germing, Ulrich ;
Haase, Detlef .
BLOOD, 2012, 120 (12) :2454-2465
[4]   Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review [J].
Park, Sophie ;
Greenberg, Peter ;
Yucel, Aylin ;
Farmer, Caroline ;
O'Neill, Frank ;
Brandao, Cisio De Oliveira ;
Fenaux, Pierre .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (02) :134-160
[5]   Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion- dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial [J].
Platzbecker, Uwe ;
Della Porta, Matteo Giovanni ;
Santini, Valeria ;
Zeidan, Amer M. ;
Komrokji, Rami S. ;
Shortt, Jake ;
Valcarcel, David ;
Jonasova, Anna ;
Dimicoli-Salazar, Sophie ;
Tiong, Ing Soo ;
Lin, Chien-Chin ;
Li, Jiahui ;
Zhang, Jennie ;
Giuseppi, Ana Carolina ;
Kreitz, Sandra ;
Pozharskaya, Veronika ;
Keeperman, Karen L. ;
Rose, Shelonitda ;
Shetty, Jeevan K. ;
Hayati, Sheida ;
Vodala, Sadanand ;
Prebet, Thomas ;
Degulys, Andrius ;
Paolini, Stefania ;
Cluzeau, Thomas ;
Fenaux, Pierre ;
Garcia-Manero, Guillermo .
LANCET, 2023, 402 (10399) :373-385